Sonoma Pharmaceuticals (NASDAQ:SNOA) reported quarterly losses of $(0.33) per share which missed the analyst consensus estimate of $(0.24) by 37.5 percent. This is a 31.25 percent increase over losses of $(0.48) per share from the same period last year. The company reported quarterly sales of $5.561 million which missed the analyst consensus estimate of $5.565 million by 0.08 percent. This is a 48.14 percent increase over sales of $3.754 million the same period last year.